NASDAQ
Aytu BioPharma, Inc. (AYTU) has a current ratio of 1.26x as of Monday, May 25, 2026. This represents a 27.42% increase compared to its 12-month average of 0.99x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.